Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997

Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997–2002)

Published:2006-01 Issue:1 Volume:27 Page:69-72
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Masterton Robert G.,Turner Philip J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. Determining the value of antimicrobial surveillance programs;Jones;Diagn Microbiol Infect Dis,2001

2. The MYSTIC (meropenem yearly susceptibility test information collection) programme;Turner;Int J Antimicrob Agents,1999

3. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalised in European medical centres: 6-year report of the MYSTIC surveillance study (1997–2002);Turner;Diagn Microbiol Infect Dis,2005

4. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview;Turner;J Antimicrob Chemother,2000

5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial test for bacteria that grow aerobically. Document M7-A6. Wayne, PA: NCCLS; 2003.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients;Journal of Clinical Pharmacy and Therapeutics;2017-02-01

2. Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins;Journal of Microbiology, Immunology and Infection;2015-04

3. Novel therapeutic strategies to counterPseudomonas aeruginosainfections;Expert Review of Anti-infective Therapy;2012-02

4. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study;BMC Infectious Diseases;2010-03-18

5. The new treatment paradigm and the role of carbapenems;International Journal of Antimicrobial Agents;2009-02